IL134778A0 - Pharmaceutical compositions for oral administration of molecular iodine - Google Patents

Pharmaceutical compositions for oral administration of molecular iodine

Info

Publication number
IL134778A0
IL134778A0 IL13477898A IL13477898A IL134778A0 IL 134778 A0 IL134778 A0 IL 134778A0 IL 13477898 A IL13477898 A IL 13477898A IL 13477898 A IL13477898 A IL 13477898A IL 134778 A0 IL134778 A0 IL 134778A0
Authority
IL
Israel
Prior art keywords
iodine
mammal
molecular iodine
molecular
pharmaceutical compositions
Prior art date
Application number
IL13477898A
Other languages
English (en)
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of IL134778A0 publication Critical patent/IL134778A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13477898A 1997-10-29 1998-10-21 Pharmaceutical compositions for oral administration of molecular iodine IL134778A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (1)

Publication Number Publication Date
IL134778A0 true IL134778A0 (en) 2001-04-30

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13477898A IL134778A0 (en) 1997-10-29 1998-10-21 Pharmaceutical compositions for oral administration of molecular iodine

Country Status (17)

Country Link
US (1) US5885592A (https=)
EP (1) EP1024815B1 (https=)
JP (1) JP4187410B2 (https=)
KR (1) KR100412219B1 (https=)
CN (1) CN1150904C (https=)
AT (1) ATE231725T1 (https=)
AU (1) AU750627B2 (https=)
BR (1) BR9812588A (https=)
CA (1) CA2301503C (https=)
DE (1) DE69811105T2 (https=)
DK (1) DK1024815T3 (https=)
ES (1) ES2191973T3 (https=)
IL (1) IL134778A0 (https=)
NO (1) NO20001673L (https=)
PT (1) PT1024815E (https=)
RU (1) RU2213564C2 (https=)
WO (1) WO1999021567A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
AU1693099A (en) * 1998-01-06 1999-07-26 Fujisawa Pharmaceutical Co., Ltd. Solid preparation of iodophor and its manufacturing methods
WO1999065538A1 (en) 1998-06-19 1999-12-23 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
ATE320831T1 (de) * 2000-10-06 2006-04-15 Dmg Italia Srl Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
ES2359818T3 (es) * 2003-06-20 2011-05-27 Hill's Pet Nutrition, Inc. Métodos para hipertiroidismo en un gato y composición que comprende yodo limitado.
CN101374420B (zh) * 2006-01-26 2016-11-09 希尔氏宠物营养品公司 治疗猫科动物的甲状腺机能亢进的方法和组合物
JP5637683B2 (ja) * 2006-05-12 2014-12-10 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 甲状腺機能亢進症のネコ科動物において慢性腎不全を予防又は治療するための組成物及び方法
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
BRPI0713634A2 (pt) * 2006-07-03 2012-10-23 Hills Pet Nutrition Inc uso de iodo ou selênio, composição e kit para prevenir e/ou tratar uma doença cardiovascular em um felino com hipertiroidismo, e, meio para comunicar informação
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
US20140072598A1 (en) * 2011-05-16 2014-03-13 Shokan Sabirkhanovich Begaliev Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
WO2015080984A1 (en) * 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
AU2015241297B2 (en) 2014-03-31 2019-03-28 Iotech International, Inc. Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
KR102697203B1 (ko) 2016-07-21 2024-08-22 아이2퓨어 코프. 연화성 국소 소독제
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
CN116367845A (zh) 2020-08-13 2023-06-30 I2普乐公司 高浓度分子碘组合物，药物制剂，制备和用途
US20240350534A1 (en) * 2020-12-12 2024-10-24 Iocure, Inc. Iodine delivery compounds
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
KR20010030861A (ko) 2001-04-16
PT1024815E (pt) 2003-06-30
US5885592A (en) 1999-03-23
ATE231725T1 (de) 2003-02-15
CA2301503A1 (en) 1999-05-06
CA2301503C (en) 2005-01-04
CN1272789A (zh) 2000-11-08
DK1024815T3 (da) 2003-05-19
NO20001673D0 (no) 2000-03-31
WO1999021567A1 (en) 1999-05-06
JP4187410B2 (ja) 2008-11-26
DE69811105T2 (de) 2003-11-06
EP1024815B1 (en) 2003-01-29
JP2003510243A (ja) 2003-03-18
DE69811105D1 (de) 2003-03-06
RU2213564C2 (ru) 2003-10-10
KR100412219B1 (ko) 2003-12-24
NO20001673L (no) 2000-05-24
BR9812588A (pt) 2000-07-25
EP1024815A1 (en) 2000-08-09
AU1122799A (en) 1999-05-17
CN1150904C (zh) 2004-05-26
AU750627B2 (en) 2002-07-25
ES2191973T3 (es) 2003-09-16

Similar Documents

Publication Publication Date Title
IL134778A0 (en) Pharmaceutical compositions for oral administration of molecular iodine
EP1001772A4 (en) IMPROVEMENTS IN THE ADMINISTRATION OF MULTIPLE DRUG DOSAGES
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
PT906106E (pt) Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca)
GEP20022784B (en) Celecoxib Composition
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
CA2214097A1 (en) Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
GB9212308D0 (en) Therapeutic compositions
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
EP1064950A4 (en) MEDICINE AGAINST HEPATITIS
AUPP325398A0 (en) Improved method for eradicating h. pylori
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
EP1782798A3 (en) Ascending-dose dosage form
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections
GR3007110T3 (https=)
YU28700A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
CA2197139A1 (en) A drug for the treatment of cancer
DE69814669D1 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
DE69736955D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
UA10436A (uk) Спосіб лікуваhhя виразкової хвороби шлуhку та дваhадцятипалої кишки
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees